EUCTR2007-004853-27-IT进行中（未招募）不适用
A phase IV monocentre study to evaluate palonosetron in nausea/vomiting prevention in patients with breast or colon cancer, treated with moderately aemotogenic chemotherapic agents - ND
OSPEDALE POLICLINICO S. MATTEO0 个研究点开始时间: 2007年9月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •male or female, age >/= 18, with colonrectal cancer or breast cancer, candidate to chemotherapy Folfox 4 or Folfiri or AC, AC-T, FEC o FAC, chemotherapy-naive, ...
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •prior treatment with chemotherapy or palonosetron,use of sperimental drug during 30 days before screening, nausea or vomiting during screening, intestinal obstruction, ...
研究者
相似试验
进行中（未招募）
不适用
multicenter phase II study to evaluate palonosetron +desametasone in the prevention of nausea and vomiting in patientes resected for colon cancer and treated with moderate emetogenus chemotherapy. - paol.+desam. in the prevention of nausea and vomitingpatientes resected for colon cancer and treated with moderate emetogenusMedDRA version: 9.1Level: LLTClassification code 10009944Term: Colon cancerEUCTR2006-002935-25-ITGOIM GRUPPO ONCOLOGICO MERIDIONALE
进行中（未招募）
不适用
Phase II study with Palonosetron alone in preventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkin?s Lymphomas who underwent moderately emetogenic chemotherapy - Palonosetron in NHpreventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkin?s Lymphomas who underwent moderately emetogenic chemotherapy.MedDRA version: 9.1Level: HLTClassification code 10028817Term: Nausea and vomiting symptomsEUCTR2006-003189-33-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
已完成
3 期
A randomized phase III trial of palonosetron versus palonosetron plus dexamethasone (day1) for the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy (HOPE-02)Colorectal CancerJPRN-UMIN000013249HOPE group(Hokkaido Supportive Care Oncology Project - an Expert Group Initiative)320
已完成
3 期
Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric PatientsPostoperative Nausea and VomitingNCT01395901Helsinn Healthcare SA670
已完成
3 期
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and VomitingLaparoscopic Gynecologic, Abdominal, Other SurgeryGeneral AnesthesiaNCT01568268Samsung Medical Center384